Cargando…

Utility values for age-related macular degeneration patients in Korea

PURPOSE: Age-related macular degeneration (AMD) is one of the most important causes of blindness globally and may lead to decreased quality of life. Utility values for AMD patients according to sociodemographic and clinical characteristics have been little-studied, particularly among Asian populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seulggie, Park, Sang Min, Jee, Donghyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067739/
https://www.ncbi.nlm.nih.gov/pubmed/30063734
http://dx.doi.org/10.1371/journal.pone.0201399
_version_ 1783343161556336640
author Choi, Seulggie
Park, Sang Min
Jee, Donghyun
author_facet Choi, Seulggie
Park, Sang Min
Jee, Donghyun
author_sort Choi, Seulggie
collection PubMed
description PURPOSE: Age-related macular degeneration (AMD) is one of the most important causes of blindness globally and may lead to decreased quality of life. Utility values for AMD patients according to sociodemographic and clinical characteristics have been little-studied, particularly among Asian populations. METHODS: A total of 1,283 AMD patients were identified from the Korean National Health and Nutrition Examination Survey from 2008 to 2012. A 45-degree digital retinal image for each eye was used to identify AMD patients. The utility values, calculated by the three level version of EuroQol-5D, of AMD patients according to sociodemographic and clinical characteristics were determined. The Kruskal-Wallis test was used to identify factors associated with reduced utility values among AMD patients. RESULTS: The mean utility value for AMD patients was 0.8765. Patients who were older (mean utility value 0.8339), were women (0.8488), had lower education levels (0.8287), were not employed (0.8467), and had lower household income (0.8022) had lower utility values (all p values <0.001). Utility values did not significantly differ according to AMD subtype (p value 0.729), likely due to the lack of enough power as only 48 patients had late AMD. Patients with lower best-eye visual acuity (BEVA) had lower utility values compared to those with high BEVA, even among those with high worst-eye visual acuity (WEVA) (p value <0.001). CONCLUSION: Sociodemographic factors and visual acuity are important factors in determining the quality of life among AMD patients. Preserving BEVA, regardless of WEVA, may be associated with improved quality of life.
format Online
Article
Text
id pubmed-6067739
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60677392018-08-10 Utility values for age-related macular degeneration patients in Korea Choi, Seulggie Park, Sang Min Jee, Donghyun PLoS One Research Article PURPOSE: Age-related macular degeneration (AMD) is one of the most important causes of blindness globally and may lead to decreased quality of life. Utility values for AMD patients according to sociodemographic and clinical characteristics have been little-studied, particularly among Asian populations. METHODS: A total of 1,283 AMD patients were identified from the Korean National Health and Nutrition Examination Survey from 2008 to 2012. A 45-degree digital retinal image for each eye was used to identify AMD patients. The utility values, calculated by the three level version of EuroQol-5D, of AMD patients according to sociodemographic and clinical characteristics were determined. The Kruskal-Wallis test was used to identify factors associated with reduced utility values among AMD patients. RESULTS: The mean utility value for AMD patients was 0.8765. Patients who were older (mean utility value 0.8339), were women (0.8488), had lower education levels (0.8287), were not employed (0.8467), and had lower household income (0.8022) had lower utility values (all p values <0.001). Utility values did not significantly differ according to AMD subtype (p value 0.729), likely due to the lack of enough power as only 48 patients had late AMD. Patients with lower best-eye visual acuity (BEVA) had lower utility values compared to those with high BEVA, even among those with high worst-eye visual acuity (WEVA) (p value <0.001). CONCLUSION: Sociodemographic factors and visual acuity are important factors in determining the quality of life among AMD patients. Preserving BEVA, regardless of WEVA, may be associated with improved quality of life. Public Library of Science 2018-07-31 /pmc/articles/PMC6067739/ /pubmed/30063734 http://dx.doi.org/10.1371/journal.pone.0201399 Text en © 2018 Choi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Choi, Seulggie
Park, Sang Min
Jee, Donghyun
Utility values for age-related macular degeneration patients in Korea
title Utility values for age-related macular degeneration patients in Korea
title_full Utility values for age-related macular degeneration patients in Korea
title_fullStr Utility values for age-related macular degeneration patients in Korea
title_full_unstemmed Utility values for age-related macular degeneration patients in Korea
title_short Utility values for age-related macular degeneration patients in Korea
title_sort utility values for age-related macular degeneration patients in korea
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067739/
https://www.ncbi.nlm.nih.gov/pubmed/30063734
http://dx.doi.org/10.1371/journal.pone.0201399
work_keys_str_mv AT choiseulggie utilityvaluesforagerelatedmaculardegenerationpatientsinkorea
AT parksangmin utilityvaluesforagerelatedmaculardegenerationpatientsinkorea
AT jeedonghyun utilityvaluesforagerelatedmaculardegenerationpatientsinkorea